Alexander C Fanaroff, Qian Huang, Kayla Clark, Laurie A Norton, Wendell E Kellum, Dwight Eichelberger, John C Wood, Zachary Bricker, Andrea G Dooley Wood, Greta Kemmer, Jennifer I Smith, Srinath Adusumalli, Mary Putt, Kevin G M Volpp
BACKGROUND: In patients with or at risk for atherosclerotic vascular disease, statins reduce the incidence of major adverse cardiovascular events, but the majority of U.S. adults with an indication for statin therapy are not prescribed statins at guideline-recommended intensity. Clinicians' limited time to address preventative care issues is cited as one factor contributing to gaps in statin prescribing. Centralized pharmacy services can fulfill a strategic role for population health management through outreach, education, and statin prescribing for patients at elevated ASCVD risk, but best practices for optimizing referrals of appropriate patients are unknown...
April 26, 2024: American Heart Journal